Vitamins E and C in the Prevention of Prostate and Total Cancer in Men
- 7 January 2009
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 301 (1), 52-62
- https://doi.org/10.1001/jama.2008.862
Abstract
In some observational studies, intake or blood levels of vitamins E and C have been associated with reduced risk of certain cancers.1 Basic research has provided plausible mechanisms by which antioxidant micronutrients such as vitamin E and vitamin C may delay various steps in carcinogenesis.2-4 However, definitive proof that vitamins E and C can reduce the risk of overall or site-specific cancers must rely on large-scale randomized trials.This publication has 32 references indexed in Scilit:
- Vitamins E and C in the Prevention of Cardiovascular Disease in MenJAMA, 2008
- Chronic inflammation and oxidative stress in human carcinogenesisInternational Journal of Cancer, 2007
- The SU.VI.MAX StudyArchives of Internal Medicine, 2004
- SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and designProstate Cancer and Prostatic Diseases, 2000
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseThe New England Journal of Medicine, 1996
- A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women: Rationale, design, and methodsAnnals of Epidemiology, 1995
- Estimating the effect of the run‐in on the power of the physicians' health studyStatistics in Medicine, 1991
- Dietary Factors and Risk of Breast Cancer: Combined Analysis of 12 Case--Control StudiesJNCI Journal of the National Cancer Institute, 1990
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyThe New England Journal of Medicine, 1989
- Dietary Carcinogens and AnticarcinogensScience, 1983